Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Priorix vs M-M-R II in Children 4-6 Years Old
NCT01621802Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2012
- Primary completion
- Jul 2015
- Countries
- 3
01
Overview
Phase 3, randomised trial of measles, mumps and rubella vaccine (live) in measles, mumps and rubella, sponsored by GSK. Started Jun 2012; status: completed.
02
Drugs
measles, mumps and rubella vaccine (live)
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT01621802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01621802.